A Case of Gastrointestinal Stromal Tumor of the Lower Rectum That Enabled Minimally Invasive Surgery with Imatinib Mesylate as Neoadjuvant Chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy 2021 Feb

filter terms:

A 67-year-old woman was admitted with melena. A colonoscopy detected a 50 mm submucosal tumor close to the dentate line. We diagnosed the rectal gastrointestinal stromal tumor by EUS-FNA. With the expectation of tumor shrinkage and strong hope of the patient, we started imatinib mesylate as neoadjuvant chemotherapy. A CT scan after 3 months after administration of imatinib mesylate showed the reduction of the size to 35 mm. We operated transanal endoscopic surgery considering the localization of the tumor. From histopathological findings, the tumor was low risk in the modified-Fletcher classification, and low risk in the Miettinen classification. Eight months after the operation, no recurrence was observed without further adjuvant chemotherapy. In this case, we were able to resect the tumor without injuring the film of tumor by operating transanal endoscopic surgery, because of tumor shrinkage with imatinib mesylate as neoadjuvant chemotherapy. I considered that using imatinib mesylate preoperatively was contributed to minimally invasive surgery.

Citation

Ko Kanesada, Nobuaki Suzuki, Shin Yoshida, Shinobu Tomochika, Hiroto Matsui, Satoshi Matsukuma, Yoshitaro Shindo, Yukio Tokumitsu, Yusaku Watanabe, Michihisa Iida, Shigeru Takeda, Tatsuya Ioka, Shoichi Hazama, Soutai Kimura, Hiroaki Nagano. A Case of Gastrointestinal Stromal Tumor of the Lower Rectum That Enabled Minimally Invasive Surgery with Imatinib Mesylate as Neoadjuvant Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy. 2021 Feb;48(2):269-272